1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Obinutuzumab for untreated advanced follicular lymphoma

Technology appraisal guidance [TA513] Published: 21 March 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 230 KB 21 March 2018  

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 458 KB 09 February 2018  
  • Committee papers PDF 1.51 MB 09 February 2018  
  • Public committee slides PDF 1.22 MB 09 February 2018  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document PDF 483 KB 14 September 2017  
  • Committee papers PDF 29.76 MB 14 September 2017  
  • Public committee slides PDF 1011 KB 14 September 2017  

Invitation to participate

  • Final scope PDF 220 KB 15 March 2017  
  • Final matrix PDF 263 KB 15 March 2017  
  • NICE's response to comments on the draft scope and provisional matrix PDF 195 KB 15 March 2017  
  • Equality impact assessment (Scoping) PDF 174 KB 15 March 2017